[1] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[2] |
ZHENG Yujing, ZHAO Zinan, JIN Pengfei, ZHAO Fei, HU Xin, ZHANG Yatong.
Active monitoring of adverse reactions of capecitabine-induced hand-foot syndrome based on the hospital information system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 441-443.
|
[3] |
HUANG Yanli, XIE Yanming, WANG Lianxin, SUN Linxi, LIU Huan, ZHUANG Yunni.
Clinical applications of Ciwujia injection in elderly patients in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 935-939.
|
[4] |
SU Xinxin, ZHAO Xiaoxiao, XIE Yanming.
Real-world analysis of combined administration of elemene emulsion injection in patients with liver cancer
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 929-934.
|
[5] |
SUN Chunquan, XIE Yanming, HOU Hengyue.
Data mining of clinical characteristics and combined medications of 4 832 patients with heart failure treated with Shengmai injection
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 130-133.
|
[6] |
SUN Chunquan, XIE Yanming, HOU Hengyue.
Clinical characteristics and combined medication of Shengmai injection in the treatment of 9215 elderly patients with cardiovascular diseases
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 36-40.
|
[7] |
CHENG Fengjingming, XIE Yanming, WANG Lianxin, MIAO Yu.
Effect of Mailuoshutong Pills on Renal Function Indexes in the Real World Based on Propensity Scores
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 537-541.
|
[8] |
ZHOU Hong, JIN Hongchang, QIN Jinfeng, ZHAO Feiyu, HE Renxian, XIE Lixia, TIAN Xiaodong.
Establishment and Application of Intelligent Reporting System for Adverse Drug Reactions in Hospitals
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(2): 93-97.
|
[9] |
WANG Qing, REN Wei, YANG Jijiang.
Impact of E2B(R3) Implementation on Information System Construction in Drug Safety Related Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(10): 591-593.
|
[10] |
YU Chao, XU Yu-ming, LI Xin-ling, WANG Ling, ZHOU Juan, WAN Kai-hua, XU Jin, YUAN Xin-dong .
Demand Investigation of Interconnection between Hospital Information System and National Adverse Drug Reaction Monitoring System in China
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(3): 154-158.
|
[11] |
WANG Ling.
Study on Adverse Drug Reaction Monitoring Based on Hospital Information System
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(4): 229-231.
|
[12] |
WANG Ling.
Study on Application of Electronic Healthcare Records in Pharmacovigilance in US and EU
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(3): 156-159.
|
[13] |
DENG Jian-xiong, WANG Ling, CHEN Wen-ge, SHU Ting, ZHANG Ye-xiang.
Research and Application of Adverse Drug Reaction Rapid Reporting and Intelligent Searching System Based on HIS
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(12): 731-734.
|
[14] |
WANG, Ling.
Opportunities and Challenges in Using Medical Big Data to Monitor and Evaluate Drug Safety
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(11): 660-664.
|
[15] |
CAO Xiu-Qin, SONG Jin-Bo.
Application of Information System for Drug Safety Monitoring of Intravenous Drip in Outpatient Department
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(5): 306-308.
|